Clinical trial Recruiting at 2 sites Observational Ages 24 Months to 70

Exploring genetic factors in autism and related disorders

Official title: Study of the Genetic Factors Involved in Autism and Related Disorders

Run by Institut National de la Santé Et de la Recherche Médicale, France · NCT04727489 · Data updated 2026-11-12

This study is trying to find out how certain genes might be linked to autism and related disorders by looking closely at genetic variations in large groups of people.

Quick facts

Study typeObservational
Ages24 Months to 70 Years
SexAll
Enrollment3800 (estimated)
SponsorInstitut National de la Santé Et de la Recherche Médicale, France
Government
Locations6 sites (Grenoble, Grenoble and 5 other locations)
StatusRecruiting
StartedMarch 30, 2021
Main results expectedMarch 2036
Study endsMarch 2036
Registry record updatedDecember 23, 2025
Trial IDNCT04727489 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals diagnosed with Autism Spectrum Disorder aged 24 months or older, as well as control participants without ASD.

Probably not a fit

Patients who do not meet the diagnostic criteria for Autism Spectrum Disorder or are unable to provide informed consent may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to investigate the genetic variations in synaptic pathways associated with Autism Spectrum Disorder (ASD) using large cohorts of patients. Researchers will perform targeted sequencing of specific synaptic genes, focusing on both coding and regulatory regions that have not been previously tested. The study will also analyze genomic data from various sequencing methods to establish genotype/phenotype correlations and identify neuronal phenotypes linked to genetic mutations. This comprehensive approach seeks to enhance understanding of the genetic underpinnings of ASD for future therapeutic development.

Why it matters

Potential benefit: If successful, this research could lead to targeted therapies for Autism Spectrum Disorder based on genetic insights.

How similar studies have gone: Previous studies have shown promise in identifying genetic factors related to Autism Spectrum Disorder, making this approach both relevant and potentially impactful.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria---------------------------------------------------------------------------------------------------

Probands with Autism Spectrum Disorder

* Meet the diagnostic criteria for ASD of the DSM-5 \[American Psychiatric Association, 2013\] based on a consensus between the clinical expertise of expert clinicians, the scores of the Autism Diagnostic Interview-Revised (ADI-R) (Rutter et al, 2003) and those of the Autism Diagnosis Observation Schedule (ADOS-2) (Lord et al, 2012)
* Be at least 24 months (no upper age limit)
* Somatic and Intellectual state compatible with a blood test
* Affiliation to the social insurance
* Signature of informed consent by the applicant or by holders of parental authority if the subject is a minor or by the guardian if the subject is under guardianship

Controls without ASD

* At least 24 months old
* Somatic and Intellectual state compatible with a blood test
* Affiliation to the social insurance
* Signature of informed consent by the subject or by holders of parental authority if the subject is a minor or by the guardian if the subject is under guardianship

Relatives of the probands with ASD or of controls without ASD

* At least 24 months old
* Somatic and Intellectual state compatible with a blood test
* Affiliation to the social insurance
* Signature of informed consent by the subject or by holders of parental authority if the subject is a minor or by the guardian if the subject is under guardianship

Exclusion Criteria --------------------------------------------------------------------------------------------------

Probands with Autism Spectrum Disorder

* Severe Intelectual Deficiency (IQ,35 or developmental age \<18 months)

  ●. Personal psychiatric history (schizophrenia, bipolar disorder, substance use disorder (except tobacco), recurrent depression disorder, severe instable anxiety disorder)
* Personal neurologic history (epilepsy, or severe neurological disease)

Relatives of the probands with ASD, of the controls or the controls:

● Medical condition (psychiatric or somatic) not compatible with the inclusion

Where it's running

  • CIC, CHU Bordeaux
    Bordeaux, France
    Recruiting
  • CRA, Hopital Charles Perrens, Bordeaux
    Bordeaux, France
    Recruiting
  • Centre de rehabilitation psychosociale, Hopital Saint Egreve
    Grenoble, Grenoble, France
    Not yet recruiting
  • CIC, H. Mondor, Creteil
    Créteil, France
    Not yet recruiting
  • Albert Chenevier Hospital
    Créteil, Île-de-France Region, France
    Not yet recruiting
  • Robert Debré Hospital
    Paris, Île-de-France Region, France
    Not yet recruiting

Study contacts

  • Principal investigator: Richard Delorme, M.D, Ph.D — Institut National de la Santé Et de la Recherche Médicale, France
  • Study coordinator: Richard Delorme, M.D, Ph.D
  • Email: richard.delorme@aphp.fr
  • Phone: +33662725334

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.